Urgent Warning for Blood Pressure Medication Users
British health authorities have issued an important safety advisory for those taking the commonly prescribed blood pressure medicine, lercanidipine hydrochloride. There’s a possibility that certain patients might accidentally use twice the dose they were prescribed and suffer serious side negative effects.
What’s the Problem?
- Problem with mislabeling: A few 20mg tablets were mistakenly being labeled as tablets of 10 mg. It could lead to people accidentally increasing their dosage.
- Potential Side Effects: Overdosing on lercanidipine may cause:
-
- Heartbeats that are irregular or fast
- Dizziness
- Drowsiness
What Should Patients Check?
If you’re taking lercanidipine hydrochloride look at the following information on the label of your medicine:
- Batch Number: MD4L07
- Expiry Date: January 2028
- Generic Medications Online Pharmacy
The information printed is directly on the foil the blister package.
More than 7700 of the affected packages are sold via Recordati Pharmaceuticals Limited, according to the Medicines and Healthcare Products Regulatory Agency (MHRA).
Immediate Actions for Affected Patients
- On a 10mg Dosage?
-
-
- If you have a pack that matches affected batch, you should contact your doctor, pharmacist as well as NHS 111 immediately.
- If you’re unable to contact a medical professional, try taking one half 20 mg tablets to temporarily treat the issue until you receive further advice.
-
- On a 20mg Dosage?
-
-
- Make sure that the tablets you are taking are correctly labeled. Continue your treatment as directed.
- Talk to your pharmacist if encounter any issues or any inconsistencies.
-
Guidance for Healthcare Professionals
- Pharmacists are asked to immediately cease the supply of medication from the affected batch, and send it back to the manufacturer.
Why This Matters
Lercanidipine is a vital treatment for high blood pressure, by enhancing the capacity of the heart’s pumping blood efficiently. With the number of prescriptions reaching 4 million handed out in England in the last year errors like these can have a significant impact on public health.
Safety First
The Dr. Alison Cave, Chief Safety Officer of the MHRA She emphasized that “Patient safety is our top priority. Please check your medication packaging and follow our guidance to ensure you are taking the correct dosage.”
Recordati Pharmaceuticals Limited has initiated the recall of products that are affected and still available for sale.
Final Advice
- If you suspect you’ve consumed greater than the prescribed dosage If you suspect that you’ve taken more than your prescribed dose, call NHS 111 right away.
- Be sure to carefully examine the batch number as well as the dosage on each medication’s packaging.
Keep yourself informed and protected! Inform those you know who could be impacted.